MicorRNAomics, metabolomics and proteomics study on precision medication of tacrolimus in liver transplant recipients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033587

Enrollment

Unknown

Registered

2020-06-06

Start date

2020-06-22

Completion date

Unknown

Last updated

2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver transplantation

Interventions

case series:N/A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who received single organ transplantation in our hospital for the first time; 2. The patients who received tacrolimus + mycophenolate mofetil + glucocorticoid immunosuppression after operation; 3. Patients aged 18-60 years old, regardless of gender; 4. Patients who can carry out blood concentration test in our hospital regularly.

Exclusion criteria

Exclusion criteria: 1. Patients with serious lack of electronic medical records; 2. Patients with multiple organ transplantation; 3. Patients with ABO blood group incompatibility; 4. Patients who switched immunosuppressive regimens midway.

Design outcomes

Primary

Measure	Time frame
Pharmacokinetics of tacrolimus;	—

Secondary

Measure	Time frame
Rejection;Graft loss;	—

Countries

China

Contacts

Public ContactZhu Huaijun

Gulou Hospital Affiliated to Medical College of Nanjing University

huaijun.zhu@gmail.com+86 13776672178

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026